iRhythm announces results presented at HRS2025

iRhythm (IRTC) Technologies announced results from a large real-world retrospective analysis presented at the Heart Rhythm Society’s annual meeting, HRS2025, held April 24-27 in San Diego, CA, The Assessment of Variation in AmbuLatory Cardiac MONitoring: Real-World Evidence of Commercially Insured Beneficiaries, AVALON, study-drawing on claims data from a cohort of 428,707 commercially insured patients-represents the largest real-world comparative evaluation of ambulatory cardiac monitoring, ACM, among this population to date, and reinforces the clinical superiority of the Zio long-term continuous monitoring, LTCM, service. The Zio LTCM service consists of a prescription-only, patch-based ECG monitoring device that captures up to 14 days of continuous, uninterrupted data, and the ZEUS system with an FDA-cleared AI algorithm clinically proven to perform at the level of cardiologists. The system delivers an end-of-wear report that is reviewed and validated by qualified cardiac technicians, with a 99% physician agreement rate.